3-BUTYL-3-ETHYL-2,3,4,5-TETRAHYDRO-7-METHOXY-5-PHENYL-1,4-BENZOTHIAZEPINE-8-METHANAMINE 1,1-DIOXIDE, (3R,5R)-
UNII LFV8QE5ZKV
Substance Identification & Data
This profile provides standardized clinical and technical data for 3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-5-phenyl-1,4-benzothiazepine-8-methanamine 1,1-dioxide, (3r,5r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LFV8QE5ZKV.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1345983-52-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H32N2O3S RCOCWDOJSUPGPF-DHIUTWEWSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-5-phenyl-1,4-benzothiazepine-8-methanamine 1,1-dioxide, (3r,5r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.